Role of lipopolysaccharide and cecal ligation and puncture on blood coagulation and inflammation in sensitive and resistant mice models

被引:38
作者
Corral, J
Yélamos, J
Hernández-Espinosa, D
Monreal, Y
Mota, R
Arcas, I
Miñano, A
Parrilla, P
Vicente, V
机构
[1] Univ Murcia, Ctr Reg Hemodonac, Dept Med, Murcia 30003, Spain
[2] Hosp Virgen Arrixaca, Dept Biochem, Murcia, Spain
[3] Hosp Virgen Arrixaca, Dept Mol Biol B, Murcia, Spain
[4] Hosp Virgen Arrixaca, Dept Immunol, Murcia, Spain
[5] Hosp Virgen Arrixaca, Dept Surg, Murcia, Spain
[6] Univ Murcia, Dept Pathol, Murcia 30003, Spain
关键词
D O I
10.1016/S0002-9440(10)62329-2
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The hemostatic system is severely disturbed during endotoxemia, leading to a hypercoagulable state. However, it remains uncertain to what extent hypercoagulability is the critical factor in determining the clinical course rather than just the consequence of a severe systemic inflammatory response. To answer this question, we evaluated the evolution of hemostatic and inflammatory markers, as well as histological features, in mice sensitive and resistant to two models of endotoxemia: lipopolysaccharide-injection and cecal ligation puncture. Genetic (knockout mice) and pharmacological (PJ34) blockade of the nuclear enzyme PARP-1 was used to achieve resistance to the endotoxemia. in both models, endotoxemia. resulted in antithrombin deficiency, decreased platelets, and fibrin deposition in organs, which were similar in all groups of mice. By contrast, proinflammatory mediators, inflammatory cell infiltration (especially that mediated by mononuclear cells), and organ degeneration were more intense in sensitive animals. Further studies supported a negative role for the triggering of the coagulation cascade in the mortality associated with the endotoxic shock. Hirudin had a minor effect on cell infiltration and organ damage, despite causing a potent inhibition of fibrin deposition. on the other hand, a sublethal dose of lipopolysaccharide yielded significant fibrin deposition but weak activation of the inflammatory response. Our results suggest that activation of coagulation by endotoxemia is severe and independent of the inflammatory response. However, such activation may act with fibrin deposition to have a minor influence on survival in sepsis.
引用
收藏
页码:1089 / 1098
页数:10
相关论文
共 39 条
  • [1] Efficacy and safety of recombinant human activated protein C for severe sepsis.
    Bernard, GR
    Vincent, JL
    Laterre, P
    LaRosa, SP
    Dhainaut, JF
    Lopez-Rodriguez, A
    Steingrub, JS
    Garber, GE
    Helterbrand, JD
    Ely, EW
    Fisher, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (10) : 699 - 709
  • [2] Transcription regulation of TNF-α-early response genes by poly(ADP-ribose) polymerase-1 in murine heart endothelial cells
    Carrillo, A
    Monreal, Y
    Ramírez, P
    Marin, L
    Parrilla, P
    Oliver, FJ
    Yélamos, J
    [J]. NUCLEIC ACIDS RESEARCH, 2004, 32 (02) : 757 - 766
  • [3] Coagulopathy of sepsis
    Dempfle, CE
    [J]. THROMBOSIS AND HAEMOSTASIS, 2004, 91 (02) : 213 - 224
  • [4] Requirement of poly(ADP-ribose) polymerase in recovery from DNA damage in mice and in cells
    deMurcia, JM
    Niedergang, C
    Trucco, C
    Ricoul, M
    Dutrillaux, B
    Mark, M
    Oliver, FJ
    Masson, M
    Dierich, A
    LeMeur, M
    Walztinger, C
    Chambon, P
    deMurcia, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (14) : 7303 - 7307
  • [5] Effect of interleukin-6 blockade on tissue factor-induced coagulation in human endotoxemia
    Derhaschnig, U
    Bergmair, D
    Marsik, C
    Schlifke, I
    Wijdenes, J
    Jilma, B
    [J]. CRITICAL CARE MEDICINE, 2004, 32 (05) : 1136 - 1140
  • [6] Tumor necrosis factor-dependent adhesions as a major protective mechanism early in septic peritonitis in mice
    Echtenacher, B
    Weigl, K
    Lehn, N
    Männel, DN
    [J]. INFECTION AND IMMUNITY, 2001, 69 (06) : 3550 - 3555
  • [7] Esmon CT, 1999, HAEMATOLOGICA, V84, P254
  • [8] Meta-analysis of controlled trials of anticoagulant therapies in patients with sepsis
    Freeman, BD
    Zehnbauer, BA
    Buchman, TG
    [J]. SHOCK, 2003, 20 (01): : 5 - 9
  • [9] SEPTIC SHOCK - PATHOGENESIS
    GLAUSER, MP
    ZANETTI, G
    BAUMGARTNER, JD
    COHEN, J
    [J]. LANCET, 1991, 338 (8769) : 732 - 736
  • [10] Coagulation inhibitor replacement during sepsis: Useless?
    Hoffman, JN
    Faist, E
    [J]. CRITICAL CARE MEDICINE, 2000, 28 (09) : S74 - S76